Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECIS: WBRT vs Intensive Chemo with ASCT in Young PCNSL Patients
NCT00863460Phase 2Active, not recruiting
- Sponsor
- Institut Curie
- Start
- Oct 2008
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thiotepa, busulfan, cyclophosphamide in primary central nervous system lymphoma (PCNSL), sponsored by Institut Curie. Started Oct 2008; status: active, not recruiting.
02
Drugs
thiotepabusulfancyclophosphamide
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT00863460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00863460.